Dr. Sarah Weiss, MD
Claim this profileRutgers Cancer Institute of New Jersey
Studies Skin Cancer
Studies Melanoma
5 reported clinical trials
8 drugs studied
Area of expertise
1Skin Cancer
Stage III
Stage IV
metastatic
2Melanoma
Stage IV
Stage III
metastatic
Affiliated Hospitals
Clinical Trials Sarah Weiss, MD is currently running
L19TNF + Doxorubicin
for Metastatic Leiomyosarcoma
The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin versus doxorubicin alone in metastatic leiomyosarcoma patients.
Recruiting1 award Phase 2
Naltrexone + Propranolol Combined With Immunotherapy
for Melanoma
This trial tests a new treatment for patients with advanced melanoma. The treatment combines drugs that block stress signals with drugs that help the immune system fight cancer. Researchers want to see if this combination is safe and effective.
Recruiting1 award Phase 115 criteria
More about Sarah Weiss, MD
Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sarah Weiss, MD has experience with
- Naltrexone
- Propranolol
- LYL845
- Doxorubicin
- L19TNF
- Pembrolizumab
Breakdown of trials Sarah Weiss, MD has run
Skin Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sarah Weiss, MD specialize in?
Sarah Weiss, MD focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage III patients, or patients who are Stage IV.
Is Sarah Weiss, MD currently recruiting for clinical trials?
Yes, Sarah Weiss, MD is currently recruiting for 2 clinical trials in New Brunswick New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Sarah Weiss, MD has studied deeply?
Yes, Sarah Weiss, MD has studied treatments such as Naltrexone, Propranolol, LYL845.
What is the best way to schedule an appointment with Sarah Weiss, MD?
Apply for one of the trials that Sarah Weiss, MD is conducting.
What is the office address of Sarah Weiss, MD?
The office of Sarah Weiss, MD is located at: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08901 United States. This is the address for their practice at the Rutgers Cancer Institute of New Jersey.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.